Tumor Regression Discovery Gets Green
Once considered an un-druggable target, UCSF's Kevan Shokat, Ph.D, discovered a novel, small molecule approach to induce tumor regression. The FDA has cleared the IND application for clinical development.
Read More
Tmunity and UCSF Announce Collaboration
Tmunity agrees to exclusive license and research collaboration with UCSF's Hideho Okada, a physician-scientist and professor of neurological surgery who studies immunotherapeutic strategies aimed at malignant brain tumors.
Read Article
The Mysterious Hormone Called Klotho
Dr. Dena Dubal worked to understand how to enhance the brain's capabilities. Now she is trying to build treatments based on these results.
Read More
We Give A Big Welcome to Anthony Francis
Innovation Ventures is proud to announce the addition of Anthony Francis, Executive Director of our Office of Technology Management group.
Read All About Him
Sana Biotechnology Launches Focusing on New Class of Medicine
UCSF's Sonja Schrepfer helps found startup Sana Biotechnology, as they launch with a focus on engineering cells to create a new class of medicines.
Read Article
CRISPR-mediated Activation to Reduce Obesity
Catalyst Awardees, Nadav Ahituv, PhD and Navneet Matharu, PhD, Apply CRISPR-mediated Activation to Obesity. Here are the results:
Read Article
Mission Bio Raises $30M To Expand Tapestri’s Reach
Mission Bio raise $30M in series B funding with Adam Abate’s work on single-cell DNA analysis platform Tapestri®.
Read Article
Principia Revealed In Generous IPO
SUCCESS STORIES
Principia Biopharma founded by Jack Taunton, began trading at $17.00 per share on the Nasdaq, raising approximately $122.2 million for immunology and cancer treatment.
Read Article
FDA Clears FOR46 For Clinical Trials
SUCCESS STORIES
Fortis Therapeutics receives FDA clearance for two INDs to treat late-stage prostate cancer and multiple myeloma.
Read Article
Health Hub Launches in Collaboration with UCSF
Next-generation nonprofit Health Hub and UC San Francisco have announced plans to bring inventors and local entrepreneurs the support and professional development needed to build successful companies.
Read Article

Who We Are

Translational technology development and commercialization is a complex process because every project is unique. Innovation Ventures is dedicated to helping the UCSF community navigate those complexities by working up-close with our research faculty and promising students to really understand their science. We have a single purpose and that is to support the transition of UCSF innovation out of the lab and into the marketplace as more fully developed therapies, with a greater confidence of success. Whether evaluating a new discovery, securing funding, seeking external partnerships, or starting new companies, Innovation Ventures is here to facilitate protection, development, and commercialization of novel and valuable healing inventions.

From Innovation...

...to Impact